Enforcement Report - Week of March 6, 2024
Enforcement Report - Week of October 25, 2023
Harrow Launches VIGAMOX® in the U.S.
Enforcement Report - Week of January 25, 2023
Enforcement Report - Week of January 18, 2023
Amid a major restructuring and the spinoff of generics unit Sandoz, Novartis isn't done shaking things up.
Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms.
Enforcement Report - Week of February 23, 2022
Enforcement Report - Week of February 2, 2022
Enforcement Report - Week of December 29, 2021